VEGFA and Alzheimer disease: AD-MSC-EVs can transfer miR-26a-5p to mouse podocytes in vitro to inhibit podocyte apoptosis by downregulating nuclear factor kappa-B (NF-κB)/VEGFA and toll-like receptor 4 (TLR4) signaling pathways (29).